[go: up one dir, main page]

ES2184770T3 - GUIDELINES OF AQUIL-CARBOXILIC ACID REPLACED WITH PHENYLL AND CARRIER OF PPERFLUORALQUILO GROUPS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AS WELL AS MEDICINES CONTAINING THEM. - Google Patents

GUIDELINES OF AQUIL-CARBOXILIC ACID REPLACED WITH PHENYLL AND CARRIER OF PPERFLUORALQUILO GROUPS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AS WELL AS MEDICINES CONTAINING THEM.

Info

Publication number
ES2184770T3
ES2184770T3 ES95100675T ES95100675T ES2184770T3 ES 2184770 T3 ES2184770 T3 ES 2184770T3 ES 95100675 T ES95100675 T ES 95100675T ES 95100675 T ES95100675 T ES 95100675T ES 2184770 T3 ES2184770 T3 ES 2184770T3
Authority
ES
Spain
Prior art keywords
rent
equal
perfluor
well
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95100675T
Other languages
Spanish (es)
Inventor
Jan-Robert Dr Schwark
Heinz-Werner Dr Kleemann
Hans-Jochen Dr Lang
Andreas Dr Weichert
Wolfgang Dr Scholz
Udo Dr Albus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4402057A external-priority patent/DE4402057A1/en
Priority claimed from DE4413615A external-priority patent/DE4413615A1/en
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2184770T3 publication Critical patent/ES2184770T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Instruments for taking body samples for diagnostic purposes; Other methods or instruments for diagnosis, e.g. for vaccination diagnosis, sex determination or ovulation-period determination; Throat striking implements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Surgery (AREA)
  • Dentistry (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN COMPUESTOS GUANIDINA ACIDO CARBOXILICO ALQUIL FENIL SUSTITUIDO QUE PORTA GRUPOS PERFLUOR ALQUIL DE LA FORMULA I CON RA) Y R(B) IGUAL A H, HAL, CN, OR(6), ALQUIL, O R - PERFLUOR ALQUIL, NR(7)R(8); R(6) IGUAL A HIDROGENO, (CICLO) ALQ(EN)IL, PERFLUOR ALQUIL, FENIL, BENCIL; R(7) Y R(8) SE DEFINEN COMO R(6); X IGUAL A 1 - 3; R(1) IGUAL A H, ALQUIL, - O0 - 1 ( CH2)0 - 1 PERFLUOR ALQUIL; R(2), R(3), R(4) Y R(5) SE DEFINEN COMO R(1), SIN EMBARGO BAJO LA CONDICION, DE QUE R(1), R(2), R(3), R(4) Y R(5) NO SON IGUALES A HIDROGENO, Y QUE R(1), R(2), R(3), R(4) Y R(5) PUEDEN SER ENTONCES SOLAMENTE ALQUIL, CUANDO AL MENOS UNO DE LOS SUSTITUYENTES R(A) O R(B) CONTIENEN UN GRUPO OR(CH2)ACBF2B+1; ASI COMO SUS SALES TOLERABLES FARMACEUTICAMENTE. SE OBTIENEN LOS COMPUESTOS I MEDIANTE TRANSFORMACION DE UN COMPUESTO II CON GUANIDINA, DONDE L ES UN GRUPO SUSTITUIBLE NUCLEOFILO LIGERO. LOS COMPUESTOS I SON INHIBIDORES DE ANTIPORTADORES SODIO PROTONES CELULARES (NA+H+ -EXCHANGER). SON APROPIADOS PARATERAPIA PREVENTIVA, A FIN DE PREVENIR LA GENESIS DE ALTA PRESION ARTERIAL, POR EJEMPLO DE HIPERTONIAS ESENCIALES.GUANIDINE ACID CARBOXILIC ACID SUBSTITUTED RENTAL COMPOUNDS ARE DESCRIBED THAT CARRIES GROUPS PERFLUOR RENT OF FORMULA I WITH RA) YR (B) EQUAL AH, HAL, CN, OR (6), RENT, OR - PERFLUOR RENT, NR (7) R ( 8); R (6) EQUAL TO HYDROGEN, (CYCLE) ALQ (EN) IL, PERFLUOR ALQUIL, FENIL, BENCIL; R (7) AND R (8) ARE DEFINED AS R (6); X EQUAL TO 1 - 3; R (1) EQUAL TO H, RENT, - O0 - 1 (CH2) 0 - 1 PERFLUOR RENT; R (2), R (3), R (4) YR (5) ARE DEFINED AS R (1), HOWEVER UNDER THE CONDITION, THAT R (1), R (2), R (3), R (4) YR (5) ARE NOT EQUAL TO HYDROGEN, AND THAT R (1), R (2), R (3), R (4) YR (5) CAN BE THEN ONLY RENT, WHEN AT LEAST ONE OF THE R (A) OR (B) SUBSTITUTES CONTAIN A GROUP OR (CH2) ACBF2B + 1; AS WELL AS YOUR TOLERABLE SALTS PHARMACEUTICALLY. THE COMPOUNDS I ARE OBTAINED BY TRANSFORMATION OF A COMPOUND II WITH GUANIDINE, WHERE IT IS A LIGHT NUCLEOPHYL REPLACABLE GROUP. THE COMPOUNDS I ARE INHIBITORS OF CELLULAR PROTON SODIUM ANTIPORTERS (NA + H + -EXCHANGER). THEY ARE APPROPRIATE PREVENTIVE PARATERAPY, IN ORDER TO PREVENT THE GENESIS OF HIGH PRESSURE ARTERIAL, FOR EXAMPLE OF ESSENTIAL HYPERTONIES.

ES95100675T 1994-01-25 1995-01-19 GUIDELINES OF AQUIL-CARBOXILIC ACID REPLACED WITH PHENYLL AND CARRIER OF PPERFLUORALQUILO GROUPS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AS WELL AS MEDICINES CONTAINING THEM. Expired - Lifetime ES2184770T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4402057A DE4402057A1 (en) 1994-01-25 1994-01-25 Perfluoroalkyl-bearing phenyl-substituted alkylcarboxylic acid guanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them
DE4413615A DE4413615A1 (en) 1994-04-19 1994-04-19 Perfluoroalkyl-bearing phenyl-substituted alkylcarboxylic acid guanidines, processes for their preparation, their use as medicaments or diagnostic agents, and medicaments containing them

Publications (1)

Publication Number Publication Date
ES2184770T3 true ES2184770T3 (en) 2003-04-16

Family

ID=25933249

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95100675T Expired - Lifetime ES2184770T3 (en) 1994-01-25 1995-01-19 GUIDELINES OF AQUIL-CARBOXILIC ACID REPLACED WITH PHENYLL AND CARRIER OF PPERFLUORALQUILO GROUPS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AS WELL AS MEDICINES CONTAINING THEM.

Country Status (15)

Country Link
US (1) US5567734A (en)
EP (1) EP0666252B1 (en)
JP (1) JP3718250B2 (en)
AT (1) ATE225332T1 (en)
AU (1) AU683328B2 (en)
CA (1) CA2140989C (en)
DE (1) DE59510395D1 (en)
DK (1) DK0666252T3 (en)
ES (1) ES2184770T3 (en)
FI (1) FI950305L (en)
HU (1) HU217617B (en)
NO (1) NO302231B1 (en)
NZ (1) NZ270370A (en)
PT (1) PT666252E (en)
TW (1) TW415937B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4412334A1 (en) * 1994-04-11 1995-10-19 Hoechst Ag Substituted N-heteroaroylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
EP0765867A1 (en) * 1995-09-27 1997-04-02 Hoechst Aktiengesellschaft Substituted benzoyl guanidines, process for their preparation, their use as antiarrhythmics or diagnostic agent as well as pharmaceuticals containing them
DE19540995A1 (en) * 1995-11-03 1997-05-07 Hoechst Ag Substituted sulfonimidamides, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
DE19542306A1 (en) * 1995-11-14 1997-05-15 Hoechst Ag Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent, and medicament containing them
PL316439A1 (en) * 1995-11-20 1997-05-26 Hoechst Ag Novel substituted derivatives of benzoyloguanidine, method of obtaining them, their application in production of pharmaceutic and diagnostic agents and pharmaceutic agent as such
DE19546736A1 (en) * 1995-12-14 1997-06-19 Hoechst Ag Substituted chromanylsulfonyl (thio) ureas, process for their preparation and their use in the manufacture of pharmaceutical preparations
DE19605610A1 (en) * 1996-02-15 1997-08-21 Hoechst Ag Substituted thiophenylalkenylcarboxylic acid guanidides, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
US6429481B1 (en) * 1997-11-14 2002-08-06 Fairchild Semiconductor Corporation Field effect transistor and method of its manufacture
AU3078500A (en) * 1999-01-27 2000-08-18 Sumitomo Pharmaceuticals Company, Limited Novel substituted guanidine derivatives and process for the preparation thereof
EP2617709B8 (en) * 2003-06-26 2022-12-21 Biotron Limited Guanidine derivatives as antiviral agents
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods
TW200808705A (en) * 2006-06-15 2008-02-16 Sanofi Aventis Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
DE2931735A1 (en) * 1979-08-04 1981-02-19 Beiersdorf Ag NEW SUBSTITUTED PHENYLACETYLGUANIDINE AND METHOD FOR THE PRODUCTION THEREOF
EP0087218B1 (en) * 1982-02-10 1985-05-02 Beecham Group Plc Guanidine derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
DE3929582A1 (en) * 1989-09-06 1991-03-07 Hoechst Ag BENZOYLGUANIDINE, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICINE AND THE MEDICINE CONTAINING IT
CZ284456B6 (en) * 1992-02-15 1998-12-16 Hoechst Aktiengesellschaft Amino substituted benzylguanidines, process of their preparation and their use for preparing medicaments
DE4318658A1 (en) * 1993-06-04 1994-12-08 Hoechst Ag Substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent, and medicament containing them

Also Published As

Publication number Publication date
FI950305A0 (en) 1995-01-24
HU9500211D0 (en) 1995-05-29
FI950305A7 (en) 1995-07-26
NZ270370A (en) 1995-09-26
NO950258D0 (en) 1995-01-24
ATE225332T1 (en) 2002-10-15
DE59510395D1 (en) 2002-11-07
EP0666252A1 (en) 1995-08-09
CA2140989A1 (en) 1995-07-26
FI950305L (en) 1995-07-26
AU1135395A (en) 1995-08-03
JP3718250B2 (en) 2005-11-24
HUT71413A (en) 1995-11-28
NO950258L (en) 1995-07-26
HU217617B (en) 2000-03-28
CA2140989C (en) 2006-09-19
DK0666252T3 (en) 2003-01-27
PT666252E (en) 2003-02-28
JPH07224022A (en) 1995-08-22
TW415937B (en) 2000-12-21
EP0666252B1 (en) 2002-10-02
US5567734A (en) 1996-10-22
NO302231B1 (en) 1998-02-09
AU683328B2 (en) 1997-11-06

Similar Documents

Publication Publication Date Title
ES2099047T1 (en) OPTICALLY PURE SALT COMPOUND OF PIRIDINYL METHYL, SULFINYL, BENZIMIDAZOLE.
ES2184770T3 (en) GUIDELINES OF AQUIL-CARBOXILIC ACID REPLACED WITH PHENYLL AND CARRIER OF PPERFLUORALQUILO GROUPS, PROCEDURE FOR THEIR PREPARATION, ITS USE AS A MEDICINAL OR DIAGNOSTIC AGENT AS WELL AS MEDICINES CONTAINING THEM.
AR241222A1 (en) Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use
ES539658A0 (en) PROCEDURE FOR THE PREPARATION OF NEW XANTHINE DERIVATIVES AND THEIR ADDITIONAL SALTS WITH APPROPRIATE ACIDS
ES8302671A1 (en) "PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES 3,4-DIHIDRO-5H-2,3-BENZODIAZEPINOS AND THEIR PHARMACEUTICALLY ACCEPTABLE ADDITIONAL SALTS".
ES2095976T3 (en) PIRAZOLOPYRIDINE COMPOUNDS AND PROCEDURE FOR THE PREPARATION.
ES2130472T3 (en) GUANIDIDES OF ALKENYL CARBOXYLLIC ACIDS SUBSTITUTED WITH PHENYL, CARRIERS OF PERFLUORO-ALKYL GROUPS, PROCEDURE FOR THEIR PREPARATION, USE AS A MEDICINAL PRODUCT OR DIAGNOSTIC AGENT, AS WELL AS A DRUG CONTAINING THEM.
GB1087243A (en) Improvements in or relating to naphthalene derivatives and the manufacture thereof
MX9307946A (en) DERIVATIVES OF SECONDARY CYCLE AMINE, A PROCEDURE FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE.
DK0406119T3 (en) New peptide derivatives, processes for their preparation and pharmaceutical agents containing them
SE8604950L (en) DEMENS IMPROVEMENT AND THERAPEUTIC AGENTS
AR247729A1 (en) PROCEDURE FOR PREPARING NEW ANTIARRHYTHMIC COMPOUNDS
ES8301883A1 (en) 1-Phenyl-2-cyclohexene-1-alkylamine derivatives, process for their preparation and medicines containing them.
ATE48835T1 (en) QUINOLYLGLYCINAMIDE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THERAPEUTIC USE AS PSYCHOTROPS.
ES8304145A1 (en) Carboxylic acid derivatives, their preparation and use as pharmaceuticals.
ES543786A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED DIETHYLAMINOALCOXY GROUP AND ITS ADDITIONAL SALTS ACIDIC AND QUATERNARY AMMONICS
FI812804L (en) 2- (1,4-BENZODIOXAN-2-YLALKYL) -IMIDAZOLER ANVAENDBARA SOM ANTIDEPRESSIVE CEILING MODEL
AR240815A2 (en) PROCEDURE FOR PREPARING DERIVATIVES OF ACIDS BENZOFURAN-5-IL AND BENZOTIOFEN-5-IL ACETICO Y PROPIONICO
ES2183492T3 (en) NEW NITRON DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES2094324T3 (en) NEW PIRROLIDINE DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES543804A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED DIALKYLAMINOALCOXY GROUP AND ITS ADDITIONAL SAILS FOR QUATERNARY AMONICS AND ACIDES
ES2057802T3 (en) NEW DERIVATIVES OF 3-AMINO-CHROMAN, PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2077473T3 (en) NEW THIOCHROMANIC COMPOUNDS, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
ES8601211A1 (en) Synergistin derivatives, their preparation and pharmaceutical compositions thereof.
ES535694A0 (en) PROCEDURE FOR THE MANUFACTURE OF BENZOIC ACID DERIVATIVES WITH ANTIMICROBIAL ACTIVITY